Namenda (memantine) Treatment Report
Generic Name: Memantine
What is Namenda?
Namenda is a brand name for the drug Memantine, the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. Namenda is a brand name owned by Forest pharmaceuticals.
Read more...
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 8 |
|
2 | ||||
| Slow my ALS progress | 8 |
|
1 | ||||
| Brain fog | 5 |
|
|
2 | |||
| Memory problems | 5 |
|
1 | ||||
| Cognition | 3 |
|
1 | ||||
| Emotional lability | 2 | 0 |
See all 46 patients currently taking Namenda
Mouse over the table for more information
Side Effects
Dosages
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
4 | 57% |
|
|
Expense
|
1 | 14% |
|
|
Personal research
|
1 | 14% |
|
|
Side effects too severe
|
1 | 14% |
|
|
Other
|
1 | 14% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 10 patient evaluations
-
- too young!
- Sex: F
- Mouth/throat: mild
- Arms: severe
- Chest: moderate
- Legs: severe
- See profile
-
-
- too young!
- since Nov 07, 2009
-
Efficacy
Major
for Slow my ALS progress
-
Side Effects
None
- Advice/Tips has slowed progression and significantly decreased my shortness of breath through out the day, which in turn has increased my energy level. best med yet See full evaluation
See all 10 patient evaluations
Report created on November 23, 2009.